141 related articles for article (PubMed ID: 16274685)
1. Autoantibodies against oxidized LDL correlate with serum concentrations of ceruloplasmin in patients with cardiovascular disease.
Awadallah SM; Hamad M; Jbarah I; Salem NM; Mubarak MS
Clin Chim Acta; 2006 Mar; 365(1-2):330-6. PubMed ID: 16274685
[TBL] [Abstract][Full Text] [Related]
2. [Antibodies against low density oxidized lipoproteins in type 2 diabetics].
Malícková K; Skrha J; Janatková I; Vanková Z; Fucíková T
Epidemiol Mikrobiol Imunol; 2004 Aug; 53(3):131-5. PubMed ID: 15524272
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
4. Differences in human antioxidized LDL autoantibodies in patients with stable and unstable angina.
Fernandes JL; Orford JL; Garcia C; Coelho OR; Gidlund M; Blotta MH
J Autoimmun; 2004 Dec; 23(4):345-52. PubMed ID: 15571928
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
Lopez LR; Hurley BL; Simpson DF; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
[TBL] [Abstract][Full Text] [Related]
6. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
7. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.
Monaco C; Crea F; Niccoli G; Summaria F; Cianflone D; Bordone R; Bellomo G; Maseri A
Eur Heart J; 2001 Sep; 22(17):1572-7. PubMed ID: 11492986
[TBL] [Abstract][Full Text] [Related]
9. IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.
Cojocaru IM; Cojocaru M; Burcin C
Rom J Intern Med; 2006; 44(2):165-70. PubMed ID: 17236297
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
Soltesz P; Veres K; Laczik R; Der H; Csipo I; Timar O; Szomjak E; Szegedi G; Szodoray P
Thromb Haemost; 2007 Aug; 98(2):413-9. PubMed ID: 17721625
[TBL] [Abstract][Full Text] [Related]
11. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
[TBL] [Abstract][Full Text] [Related]
12. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
14. Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome.
Becarevic M; Singh S; Majkic-Singh N
Clin Lab; 2008; 54(3-4):97-101. PubMed ID: 18630740
[TBL] [Abstract][Full Text] [Related]
15. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
17. The effects of metabolic control on oxidized low-density lipoprotein antibodies in children and adolescents with type 1 diabetes mellitus.
Kara C; Cetinkaya S; Sezgin N; Kinik ST
Pediatr Diabetes; 2008 Feb; 9(1):17-22. PubMed ID: 18211632
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
19. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of autoantibodies against oxidized LDL (oLAB) and blood antioxidant status in professional soccer players.
Kłapcińska B; Kempa K; Sobczak A; Sadowska-Krepa E; Jagsz S; Szołtysek I
Int J Sports Med; 2005; 26(1):71-8. PubMed ID: 15643538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
